Colorcon Inc. and Evonik Industries AG have announced the signing of a cooperation agreement for the marketing and technical support of Acryl-EZE®, aqueous acrylic enteric system.
Acryl-EZE® fully formulated coating systems are produced by Colorcon and contain EUDRAGIT® L 100-55, an Evonik product, as the key functional ingredient.
“Colorcon is a market leader in fully formulated film coating systems and Acryl-EZE® is well established in the pharmaceutical market. This new cooperation will expand our offering and bring more choices to the customers ranging from single functional excipients to fully formulated delayed release coating systems” comments Jean-Luc Herbeaux, Head of the Health Care Business Line, of Evonik Industries.
Prior to this new cooperation agreement, Acryl-EZE® was produced, distributed, marketed and supported solely by Colorcon.
The new cooperation will result in enhanced global technical support to the pharmaceutical industry through the Evonik network as well as the established Colorcon channels.
Furthermore the cooperation will create value for customers who require high performance enteric acrylic coating solutions.
“Expanding our sales and marketing activities will enable us to reach and support more customers and offer them a broader technical service together with Evonik, a leading company in delayed release polymers. We are excited to enter this new cooperation” affirms Colorcon’s CEO Martti Hedman.
Lancet Commission predicts sharp increase in global prostate cancer cases